Cargando…

Oncogenic Signalling of Growth Factor Receptors in Cancer: Mechanisms and Therapeutic Opportunities

Detalles Bibliográficos
Autor principal:	Dricu, Anica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266644/ https://www.ncbi.nlm.nih.gov/pubmed/35806381 http://dx.doi.org/10.3390/ijms23137376

Ejemplares similares

Cancer Immunology: From Molecular Mechanisms to Therapeutic Opportunities
por: Mattei, Fabrizio, et al.
Publicado: (2022)

EGFR Signaling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Opportunities
por: La Monica, Silvia
Publicado: (2022)

Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities
por: Xiong, Hanchu, et al.
Publicado: (2017)

Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis
por: Grandal, Michael Vibo, et al.
Publicado: (2008)

Transcriptomic Crosstalk between Gliomas and Telencephalic Neural Stem and Progenitor Cells for Defining Heterogeneity and Targeted Signaling Pathways
por: Deleanu, Roxana, et al.
Publicado: (2021)

Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines
por: Alexandru, Oana, et al.
Publicado: (2019)

Molecular Biology of Ovarian Cancer: From Mechanisms of Intraperitoneal Metastasis to Therapeutic Opportunities
por: Książek, Krzysztof
Publicado: (2021)

Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities
por: Bansod, Sapana, et al.
Publicado: (2021)

The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer
por: Purcaru, Oana-Stefana, et al.
Publicado: (2021)

Muscle Homeostasis and Regeneration: From Molecular Mechanisms to Therapeutic Opportunities
por: Musarò, Antonio
Publicado: (2020)

Sorting nexin-dependent therapeutic targeting of oncogenic epidermal growth factor receptor
por: Atwell, Benjamin, et al.
Publicado: (2022)

Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities
por: Liu, Dahai, et al.
Publicado: (2023)

Platelet-Derived Growth Factors: A New Therapeutic Opportunity for Treating Cardiac Fibrosis?
por: Mouton, Alan J.
Publicado: (2023)

Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities
por: Li, Siyi, et al.
Publicado: (2023)

Importance of Translational Research for Targeting Fibroblast Growth Factor Receptor Signaling in Cancer
por: Holzmann, Klaus, et al.
Publicado: (2019)

Vitamin D receptor and type 2 diabetes mellitus: Growing therapeutic opportunities
por: Manchanda, Parmeet Kaur, et al.
Publicado: (2012)

Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities
por: Schmidt, Marlene F., et al.
Publicado: (2021)

HOXA9/MEIS1 targets in leukemia: reinforced signaling networks and therapeutic opportunities
por: Zhou, Xinyue, et al.
Publicado: (2022)

Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker
por: Serban, Florentina, et al.
Publicado: (2015)

Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming
por: Márquez, Javier, et al.
Publicado: (2021)

Obesity paradox and lung cancer, metformin-based therapeutic opportunity?
por: Barrios-Bernal, Pedro, et al.
Publicado: (2023)

Cancer Stem Cells: Biological Functions and Therapeutically Targeting
por: Ciurea, Marius Eugen, et al.
Publicado: (2014)

Toll-Like Receptor Signaling Pathways—Therapeutic Opportunities
por: Zhu, Jiankun, et al.
Publicado: (2010)

EGFR mutations in sinonasal squamous tumors: oncogenic and therapeutic implications
por: Udager, Aaron M., et al.
Publicado: (2015)

Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches
por: Alexandru, Oana, et al.
Publicado: (2020)

Intracellular Pathways and Mechanisms of Colored Secondary Metabolites in Cancer Therapy
por: Sevastre, Ani-Simona, et al.
Publicado: (2022)

Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers
por: Wendt, Michael K, et al.
Publicado: (2014)

Fibroblast growth factor receptor fusions in cancer: opportunities and challenges
por: Chen, Lingfeng, et al.
Publicado: (2021)

HSP70: From Signaling Mechanisms to Therapeutics
por: Nunes, Kenia Pedrosa, et al.
Publicado: (2023)

Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival
por: Catrina, S-B, et al.
Publicado: (2005)

Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
por: Sobani, Zain A, et al.
Publicado: (2016)

The therapeutic landscape for gut bacterial infections: opportunities and limitations
por: Weiss, Adam
Publicado: (2020)

The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth
por: Luraghi, Paolo, et al.
Publicado: (2012)

Multiple mechanisms can disrupt oncogenic pathways in multiple myeloma
por: Hoang, Phuc H., et al.
Publicado: (2018)

New perspectives in glioblastoma antiangiogenic therapy
por: Popescu, Alisa Madalina, et al.
Publicado: (2015)

Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer
por: Jain, Vikram K, et al.
Publicado: (2012)

Regulation of oncogenic PI3-kinase signaling by JARID1B
por: Facompre, Nicole D., et al.
Publicado: (2017)

Why Do Cancer Cells Become “Addicted” to Oncogenic Epidermal Growth Factor Receptor?
por: Mellinghoff, Ingo
Publicado: (2007)

Disabling an oncogenic transcription factor by targeting of control kinases
por: Vakoc, Christopher R., et al.
Publicado: (2018)

SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance
por: Sun, Boshu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h8m2iblhmdvsti2jksceu892og